North America Artificial Intelligence In Precision Medicine Market Size & Outlook
The artificial intelligence in precision medicine market in North America is expected to reach a projected revenue of US$ 16,154.3 million by 2033. A compound annual growth rate of 37.1% is expected of North America artificial intelligence in precision medicine market from 2026 to 2033.
Healthcare IT
AI in Healthcare
artificial intelligence precision medicine market report
North America artificial intelligence in precision medicine market highlights
The North America artificial intelligence in precision medicine market generated a revenue of USD 1,294.6 million in 2025.
The market is expected to grow at a CAGR of 37.1% from 2026 to 2033.
In terms of segment, deep learning was the largest revenue generating technology in 2025.
Natural language processing is the most lucrative technology segment registering the fastest growth during the forecast period.
Country-wise, Mexico is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
Market revenue in 2025
USD 1,294.6 million
Market revenue in 2033
USD 16,154.3 million
Growth rate
37.1% (CAGR from 2026 to 2033)
Largest segment
Deep learning
Fastest growing segment
Natural language processing
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Deep Learning, Querying Method, Natural language processing, Context aware processing
Key market players worldwide
BioXcel Therapeutics Inc, Sanofi SA, NVIDIA Corp, Alphabet Inc Class A, International Business Machines Corp, Microsoft Corp, Intel Corp, AstraZeneca PLC, GE HealthCare Technologies Inc Common Stock, Enlitic
Other key industry trends
In terms of revenue, North America region accounted for 53.3% of the global artificial intelligence in precision medicine market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 7,102.0 million by 2033.
The Adventist nonprofit healthcare organization, Advent Health, announced in May 2021 that it would be working with the health intelligence company, Sema4. Using the software platform and tools from Sema4, the organizations will combine genomic and clinical data from Advent Health.
The collaboration represents an expansion of Advent Health's genomics and customized health initiative, including investments in precision medicine research and genetic testing, counseling, and sequencing. Similarly, in June 2019, the Icahn School of Medicine at Mount Sinai announced the launch of a USD 100 million research facility emphasizing AI and precision medicine in Manhattan in late 2021.
Precision imaging, the new Center for Genomic Health, and integrated omics & multiscale disease modeling will be the three principal research areas for the Hamilton and Amabel James Center for Artificial Intelligence and Human Health.
North America artificial intelligence precision medicine market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Artificial Intelligence In Precision Medicine Market Outlook will help companies and investors design strategic landscapes.
Deep Learning was the largest segment with a revenue share of 45.88% in 2025.
Horizon Databook has segmented the North America artificial intelligence in precision medicine market based on deep learning, querying method, natural language processing, context aware processing covering the revenue growth of each sub-segment from 2021 to 2033.
The Adventist nonprofit healthcare organization, Advent Health, announced in May 2021 that it would be working with the health intelligence company, Sema4. Using the software platform and tools from Sema4, the organizations will combine genomic and clinical data from Advent Health.
The collaboration represents an expansion of Advent Health's genomics and customized health initiative, including investments in precision medicine research and genetic testing, counseling, and sequencing. Similarly, in June 2019, the Icahn School of Medicine at Mount Sinai announced the launch of a USD 100 million research facility emphasizing AI and precision medicine in Manhattan in late 2021.
Precision imaging, the new Center for Genomic Health, and integrated omics & multiscale disease modeling will be the three principal research areas for the Hamilton and Amabel James Center for Artificial Intelligence and Human Health.
North America Artificial Intelligence In Precision Medicine Market Technology Outlook (Revenue, USD Million , 2021-2033)
Deep Learning
Querying Method
Natural language processing
Context aware processing
North America Artificial Intelligence In Precision Medicine Market Component Outlook (Revenue, USD Million , 2021-2033)
Hardware
Software
Service
North America Artificial Intelligence In Precision Medicine Market Therapeutic Application Outlook (Revenue, USD Million , 2021-2033)
Oncology
Cardiology
Neurology
Respiratory
Others
Reasons to subscribe to artificial intelligence precision medicine market report databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of artificial intelligence precision medicine market report databook
Our clientele includes a mix of artificial intelligence precision medicine market report companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America artificial intelligence precision medicine market report, including forecasts for subscribers. This continent databook contains high-level insights into North America artificial intelligence precision medicine market report from 2021 to 2033, including revenue numbers, major trends, and company profiles.
North America Artificial Intelligence In Precision Medicine Market, 2021-2033 (US$M)